S&P 500   3,783.28
DOW   30,273.87
QQQ   281.98
Free Webinar | October 11: How to Break Barriers
Investor Alert: Argentina Loaded With "White Gold" Opportunity (Ad)
Rivian Checks Off Boxes, But Still Needs a Lot to Go Right
Live Updates: Russia-Ukraine War
Rare Biden-Trump Alliance to Trigger Boom in US Lithium (Ad)
Too Soon: 3 Reasons to Wait on DocuSign Stock
OPEC+ makes big oil cut to boost prices; pump costs may rise
Investor Alert: Argentina Loaded With "White Gold" Opportunity (Ad)
Hot Potato: Lamb Weston Stock Confirms a Top 
3 Alzheimer Stocks to Buy as the Race for a Cure Heats Up
S&P 500   3,783.28
DOW   30,273.87
QQQ   281.98
Free Webinar | October 11: How to Break Barriers
Investor Alert: Argentina Loaded With "White Gold" Opportunity (Ad)
Rivian Checks Off Boxes, But Still Needs a Lot to Go Right
Live Updates: Russia-Ukraine War
Rare Biden-Trump Alliance to Trigger Boom in US Lithium (Ad)
Too Soon: 3 Reasons to Wait on DocuSign Stock
OPEC+ makes big oil cut to boost prices; pump costs may rise
Investor Alert: Argentina Loaded With "White Gold" Opportunity (Ad)
Hot Potato: Lamb Weston Stock Confirms a Top 
3 Alzheimer Stocks to Buy as the Race for a Cure Heats Up
S&P 500   3,783.28
DOW   30,273.87
QQQ   281.98
Free Webinar | October 11: How to Break Barriers
Investor Alert: Argentina Loaded With "White Gold" Opportunity (Ad)
Rivian Checks Off Boxes, But Still Needs a Lot to Go Right
Live Updates: Russia-Ukraine War
Rare Biden-Trump Alliance to Trigger Boom in US Lithium (Ad)
Too Soon: 3 Reasons to Wait on DocuSign Stock
OPEC+ makes big oil cut to boost prices; pump costs may rise
Investor Alert: Argentina Loaded With "White Gold" Opportunity (Ad)
Hot Potato: Lamb Weston Stock Confirms a Top 
3 Alzheimer Stocks to Buy as the Race for a Cure Heats Up
S&P 500   3,783.28
DOW   30,273.87
QQQ   281.98
Free Webinar | October 11: How to Break Barriers
Investor Alert: Argentina Loaded With "White Gold" Opportunity (Ad)
Rivian Checks Off Boxes, But Still Needs a Lot to Go Right
Live Updates: Russia-Ukraine War
Rare Biden-Trump Alliance to Trigger Boom in US Lithium (Ad)
Too Soon: 3 Reasons to Wait on DocuSign Stock
OPEC+ makes big oil cut to boost prices; pump costs may rise
Investor Alert: Argentina Loaded With "White Gold" Opportunity (Ad)
Hot Potato: Lamb Weston Stock Confirms a Top 
3 Alzheimer Stocks to Buy as the Race for a Cure Heats Up
CVE:MJN

Cronos Group - MJN Stock Forecast, Price & News

C$12.15
-0.23 (-1.86%)
(As of 03/2/2018)
Add
Compare
Today's Range
C$11.90
C$12.47
50-Day Range
C$12.15
C$12.15
52-Week Range
C$1.58
C$14.83
Volume
1.39 million shs
Average Volume
2.07 million shs
Market Capitalization
C$1.73 billion
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
MJN stock logo

About Cronos Group (CVE:MJN) Stock

Cronos Group Inc, formerly PharmaCan Capital Corp, is a Canada-based cannabis company. The Company operates two Licensed Producers (LPs) regulated within Health Canada's Access to Cannabis for Medical Purposes Regulations (the ACMPR) and holds a portfolio of investments in other Licensed Producers and ACMPR applicants. Its LPs, Peace Naturals Project Inc. and In The Zone Produce Ltd., are collectively located on over 125 acres of agricultural land. It also holds equity positions in Licensed Producers Whistler Medical Marijuana, Hydropothecary and Abcann Medicinals. Whistler Medical Marijuana is licensed to produce and sell medical marijuana, as well as cultivate cannabis oil. Hydropothecary is licensed to produce medical marijuana. Abcann Medicinals also has license to produce medical marijuana. With interest in five Licensed Producers and two LP applicants, it is focused on building brand portfolio providing patients with personalized care.

Receive MJN Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Cronos Group and its competitors with MarketBeat's FREE daily newsletter.

MJN Stock News Headlines

Cronos Group Inc. (CRON)
Recap: Cronos Group Q2 Earnings
Why Cronos Stock Is Getting Hammered Today
Why Cronos Group Is Plummeting Today
Cronos Group Changes Canadian Ticker to CRON
TSX:CRON (CRONOS GROUP)
TSX:AZ (ARMISTICE RESOURCES CORP.)
Cronos Group Inc. Reports Q3 2017 Financial Results
See More Headlines
Receive MJN Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Cronos Group and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry
Electronic Computer Manufacturing
Sub-Industry
Cannabis
CIK
N/A
Fax
N/A
Employees
147,000
Year Founded
N/A

Profitability

Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A

Miscellaneous

Free Float
N/A
Market Cap
C$1.73 billion
Optionable
Optionable
Beta
N/A

Key Executives

  • Michael Ryan Gorenstein
    President, Chief Executive Officer, Vice Chairman of the Board, Corporate Secretary
  • William Lawrence Hilson
    Chief Financial Officer
  • Jason Adler
    Director
  • Ryan Roebuck
    Director
  • James Rudyk
    Director
  • Alan Mark Friedman (Age 45)
    Independent Director
  • Michael Howard Krestell
    Independent Director













MJN Stock - Frequently Asked Questions

How have MJN shares performed in 2022?

Cronos Group's stock was trading at C$12.15 on January 1st, 2022. Since then, MJN stock has increased by 0.0% and is now trading at C$12.15.
View the best growth stocks for 2022 here
.

Is Cronos Group a good dividend stock?

Cronos Group (CVE:MJN) pays an annual dividend of C$1.65 per share and currently has a dividend yield of 0.00%.

What other stocks do shareholders of Cronos Group own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Cronos Group investors own include Cronos Group (CRON), Aurora Cannabis (ACB), Canopy Growth (WEED), OrganiGram (OGI), Aphria (APHA), IMV (IMV), Leaf Mobile (LEAF), Aurora Cannabis (ACB) and CanniMed Therapeutics (CMED).

What is Cronos Group's stock symbol?

Cronos Group trades on the Canadian Venture Exchange (CVE) under the ticker symbol "MJN."

How do I buy shares of Cronos Group?

Shares of MJN stock and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers.
Compare Top Brokerages Here.

What is Cronos Group's stock price today?

One share of MJN stock can currently be purchased for approximately C$12.15.

How much money does Cronos Group make?

Cronos Group (CVE:MJN) has a market capitalization of C$1.73 billion.

How many employees does Cronos Group have?

The company employs 147,000 workers across the globe.

How can I contact Cronos Group?

Cronos Group's mailing address is 720 King St W Suite 320, TORONTO, ON M5V 2T3, Canada. The official website for the company is thecronosgroup.com. The company can be reached via phone at +1-416-5040004.

This page (CVE:MJN) was last updated on 10/6/2022 by MarketBeat.com Staff

MarketBeat Resources

Premium Research Tools

MarketBeat All Access members have access to premium reports, best-in-class portfolio monitoring tools, and our latest stock picks.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies, and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau MarketBeat is rated as Great on TrustPilot

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | contact@marketbeat.com | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Privacy Policy | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see Barchart's disclaimer.